Lower levels of free factor XI and fewer bleeding events seen in patients with atrial fibrillation at moderate-to-high risk for stroke ...

Patients with atrial fibrillation are typically prescribed an anticoagulant, or blood thinner, to reduce the risk of stroke, but many may discontinue them or never receive a prescription due to ...

Abelacimab, a factor XI inhibitor, demonstrated a 62–69% reduction in major bleeding compared to rivaroxaban in atrial fibrillation patients at moderate-to-high stroke risk, with comparable safety and ...

Pharmaceuticals, a leading biotechnology company with a market capitalization of $73.8 billion, has been navigating a complex ...

A new study highlights that the experimental blood-thinner abelacimab significantly reduces bleeding risks in atrial fibrillation patients compared to standard treatments like rivaroxaban. In trial ...

Patients with a common heart rhythm disorder who took an experimental blood-thinning drug had far fewer bleeding episodes ...

Asian equities ended the week on a high note, as Mainland China and Hong Kong outperformed and the Philippines underperformed ...

Chinese model Xiao Wen Ju reflects on a stellar career, her new role as a mother, and her Lunar New Year traditions.

Atrial fibrillation (AF) is a common heart condition that affects about one in three people at some point in their lives. It ...

Ind vs Eng 3rd T20 Match Date, Time, Match Venue, Pitch Report: With India leading 2-0, they have a golden opportunity to ...

Familial hypercholesterolemia, cardiac arrest therapy, Factor XI inhibition, and tricuspid valve interventions are the topics John Mandroa, MD, discusses in this week’s podcast.